Skip navigation
Please use this identifier to cite or link to this item:
Title: Síntese, caracterização e avaliação antitumoral de novos derivados 3-Benzil-5-(Indol-3-il-Metileno)-Tiazolidina-2,4-Diona
Authors: Christianne Batista de Lacerda Pedrosa, Sybelle
Keywords: Química Medicinal; Antitumoral; Indol; Tiazolidinas
Issue Date: 31-Jan-2011
Publisher: Universidade Federal de Pernambuco
Citation: Christianne Batista de Lacerda Pedrosa, Sybelle; do Carmo Alves de Lima, Maria. Síntese, caracterização e avaliação antitumoral de novos derivados 3-Benzil-5-(Indol-3-il-Metileno)-Tiazolidina-2,4-Diona. 2011. Dissertação (Mestrado). Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife, 2011.
Abstract: The thiazolidine-2,4-dione are a class of compounds derived thiazolidine. It is a 5-membered ring containing a sulfur atom and a nitrogen atom in positions 1 and 3, respectively, and carbonyl in position 4 and 2. Data in the literature demonstrate the synthetic thiazolidinedione ligands of PPARs as and therefore play some biological activities such as hypoglycemic, antimicrobial, antitumor and anti-inflammatory. This study aimed to: synthesize new derivatives 5 - (indole-3-yl-methylene)-3-benzyl-thiazolidine-2 ,4-dione, by reactions of cyclization, addition of Michael, N-alkylation at position 3 and in the Knoevenagel condensation at position 5 of ring thiazolidine-2,4-dione. The molecules obtained were proved by infrared spectroscopic methods, hydrogen nuclear magnetic resonance and mass spectrometry. It was found that in vitro cytotoxicity of new molecules synthesized in three tumor cell lines: HT29 (colon carcinoma - human), HEP (laryngeal carcinoma - human) and NCI H-292 (human lung cancer). This analysis was part of an initial screening to determine the antitumor potential. The 3-(3-bromo-benzyl)-5-(5-bromo-1H-indole-3-yl-methylene)-thiazolidine-2,4-dione (LPSF/GQ-240) showed the best result for NCI H-292 (human lung cancer) 80.2% of inhibition and HT29 (colon carcinoma - human) 83.1% of inhibition. This antitumor activity in vivo was performed in the model where the Sarcoma-180 which showed high values of inhibition of tumor growth in three doses tested (10, 20 and 40mg/kg) of LPSF/GQ-240 compared to the negative control. These results confirm the importance of derivatives 5-(indole-3-yl-methylene)-3-benzyl-tiazolodina-2,4-dione in the fight against cancer.
Appears in Collections:Dissertações de Mestrado - Ciências Farmacêuticas

Files in This Item:
File Description SizeFormat 
arquivo6584_1.pdf732.68 kBAdobe PDFView/Open

This item is protected by original copyright

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.